New study results from Uganda strengthen the case for contraceptive self-injection

(PATH) Results from a PATH study in Uganda, now published in the journal Contraception, show that self-injection of subcutaneous DMPA may help women to continue using injectable contraception longer than women who receive traditional intramuscular injections from providers. Over the course of a 12-month study period, 81 percent of DMPA self-injection participants continued to use the product. Meanwhile, 65 percent of the 600 women who received injections from a health worker continued using the product.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2qqWUJD